针对HER-2的抗体-药物合物的心脏毒性:概述和临床影响
Ziad Zalaquett1, Maria Catherine Rita Hachem1, Ahmad Assi1
1Hôtel-Dieu de France University Hospital, Saint Joseph University of Beirut, Beirut, Lebanon.
Future oncology (London, England)
|October 7, 2024
概括
HER-2抗体-药物合物 (ADC) 显示心脏风险. 本综述详细介绍了T-DM1和T-DXd等HER-2ADC的心脏毒性,有助于临床识别和管理.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗体-药物合物 (ADC) 通过将单克隆抗体与化疗相结合,提供向癌症治疗.
- HER-2对心脏发育和生理学至关重要,使HER-2向ADC成为心脏毒性问题.
- 特拉斯图祖马布埃姆坦辛 (T-DM1) 和特拉斯图祖马布德鲁克斯坦 (T-DXd) 与心脏毒性有关,尽管往往没有临床意义.
研究的目的:
- 综合审查和描述针对HER-2的ADCs的心脏毒性概况.
- 为了提高对与HER-2ADC相关的心脏毒性的临床理解.
- 为指导更好地识别,监测和管理与HER-2ADCs相关的心脏不良事件.
主要方法:
- 关于HER-2ADC和心脏副作用的研究文献综述.
- 对与T-DM1和T-DXd相关的报告心脏毒性的分析.
- 综合了关于HER-2在心脏功能中的作用及其对ADC治疗的影响的信息.
主要成果:
- 包括T-DM1和T-DXd在内的HER-2ADC与心脏毒性有着一致的联系.
- 虽然心脏不良事件很少具有临床相关性,但它们需要仔细监测.
- 基线心脏评估和持续监测对于接受HER-2ADC的患者至关重要.
结论:
- 由于潜在的心脏毒性,HER-2 ADCs需要警的心脏监测.
- 更好地了解心脏不良事件将优化患者管理.
- 早期检测和管理策略对于安全有效地使用HER-2ADCs至关重要.
更多相关视频
13:59High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
Published on: August 18, 2023
1.9K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
395
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
395
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:26Heart Failure Drugs: Inotropic Agents
535
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
535
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K